| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441258 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
The recommended MTD schedule for future studies was 30Â mg thrice weekly, which exceeds the target inhibition level observed in preclinical models to promote tumour regression in humans.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shubham Pant, Suzanne F. Jones, Carla D. Kurkjian, Jeffrey R. Infante, Kathleen N. Moore, Howard A. Burris, Donald S. McMeekin, Karim A. Benhadji, Bharvin K.R. Patel, Martin J. Frenzel, Jonathan D. Kursar, Maciej J. Zamek-Gliszczynski, Eunice S.M. Yuen,